E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Clinical trial NCT02858310 · COMPLETED

Trial details

NCT number: NCT02858310
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Papillomavirus Infections Cervical Intraepithelial Neoplasia Carcinoma In Situ Vulvar Neoplasms Vulvar Diseases

Start date: 2017-01-27
Primary completion: 2025-07-02
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.